GLP-1 Drugs May Cause Persistent Hair Loss in Men, Studies Find

Key points

• A systematic review in Science Progress found male patients with higher GLP-1 gene activity were 7% more likely to experience hair loss.
• A BMJ study showed GLP-1 users were 37% to 68% more likely to report hair loss than users of other diabetes medications like SGLT2i or DPP4i.
• Researchers at NYU Langone Health identified a genetic link between GLP-1 use and androgenetic alopecia, the most common form of male pattern baldness.
• The hair loss may not be temporary, suggesting a mechanism beyond the rapid weight loss typically associated with these drugs.
• Future research may allow for genetic screening to identify patients at higher risk for hair loss before prescribing GLP-1 medications.

Background

GLP-1 drugs have seen a surge in prescriptions since their FDA approval in 2020, with an estimated 12% of Americans using them for weight loss. Previous concerns included potential adverse effects, with the MHRA reporting over 150 deaths linked to these drugs in 2026, though regulators noted benefits generally outweigh risks. This new focus on hair loss adds another dimension to the safety profile of these widely used medications.

How outlets are covering it

The Daily Beast and NBC News emphasize the potential for persistent hair loss, moving beyond the temporary shedding often attributed to rapid weight loss. The Daily Beast highlights the genetic aspect, noting a 7% increased risk for men with specific gene variants. NBC News frames the issue as a side effect that may worsen or speed up hair loss in some men. Penn Today provides a broader population-level perspective, comparing GLP-1 use to other diabetes medications and finding significantly higher hair loss rates. NYU Langone Health focuses on the genetic link, suggesting that future screening could help identify at-risk patients. The outlets agree on the concerning nature of the findings but differ in their emphasis on genetic vs. population-level data.

Why it matters

As GLP-1 drugs become more widely used for weight loss and diabetes management, understanding their long-term side effects is crucial. Hair loss, particularly if persistent, could impact patient quality of life and adherence to treatment. Identifying genetic risk factors could lead to more personalized medicine, allowing doctors to screen patients before prescribing these drugs. This could also inform the development of combination treatments to prevent hair loss, improving overall patient outcomes.

What to watch

Further research is needed to understand the biological mechanisms behind GLP-1-induced hair loss. Researchers plan to investigate whether the links seen in men apply to women as well. There is potential for developing genetic screening tools to identify patients at higher risk for hair loss before prescribing GLP-1 medications. Additionally, combination treatments, such as minoxidil, may be explored to prevent hair loss in at-risk patients. Ongoing studies will help clarify the extent and nature of this side effect, guiding future medical practices.